T. Tschopp

1.1k total citations
23 papers, 863 citations indexed

About

T. Tschopp is a scholar working on Hematology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, T. Tschopp has authored 23 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 7 papers in Surgery and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in T. Tschopp's work include Platelet Disorders and Treatments (13 papers), Blood Coagulation and Thrombosis Mechanisms (11 papers) and Blood properties and coagulation (6 papers). T. Tschopp is often cited by papers focused on Platelet Disorders and Treatments (13 papers), Blood Coagulation and Thrombosis Mechanisms (11 papers) and Blood properties and coagulation (6 papers). T. Tschopp collaborates with scholars based in Switzerland, Slovenia and France. T. Tschopp's co-authors include HR Baumgartner, Hans R. Baumgartner, Daniel Kirchhofer, Paul Hadváry, Dominique Meyer, Reto Müggli, VT Turitto, HJ Weiss, Dalia Cohen and Alain Gast and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Blood.

In The Last Decade

T. Tschopp

23 papers receiving 761 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Tschopp Switzerland 14 556 269 223 188 180 23 863
KS Sakariassen Netherlands 13 800 1.4× 201 0.7× 271 1.2× 181 1.0× 118 0.7× 21 1.1k
AD Michelson United States 8 497 0.9× 194 0.7× 128 0.6× 182 1.0× 81 0.5× 11 705
VT Turitto United States 13 937 1.7× 314 1.2× 367 1.6× 253 1.3× 175 1.0× 19 1.3k
Dorothée Kling Switzerland 9 604 1.1× 211 0.8× 168 0.8× 182 1.0× 239 1.3× 12 1.1k
M Drillings United States 8 508 0.9× 172 0.6× 190 0.9× 98 0.5× 82 0.5× 8 864
J. Stibbe Netherlands 14 383 0.7× 213 0.8× 187 0.8× 295 1.6× 148 0.8× 34 845
P. G. De Groot Netherlands 11 400 0.7× 116 0.4× 142 0.6× 148 0.8× 57 0.3× 19 671
Hideo Kagawa Japan 16 570 1.0× 187 0.7× 149 0.7× 117 0.6× 99 0.6× 43 1.1k
David Stern United States 13 221 0.4× 144 0.5× 84 0.4× 272 1.4× 51 0.3× 23 711
AK Kakkar United Kingdom 7 170 0.3× 264 1.0× 88 0.4× 164 0.9× 416 2.3× 11 755

Countries citing papers authored by T. Tschopp

Since Specialization
Citations

This map shows the geographic impact of T. Tschopp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Tschopp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Tschopp more than expected).

Fields of papers citing papers by T. Tschopp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Tschopp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Tschopp. The network helps show where T. Tschopp may publish in the future.

Co-authorship network of co-authors of T. Tschopp

This figure shows the co-authorship network connecting the top 25 collaborators of T. Tschopp. A scholar is included among the top collaborators of T. Tschopp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Tschopp. T. Tschopp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zega, Anamarija, Gregor Mlinšek, Simona Golič Grdadolnik, et al.. (2001). Design and structure–activity relationship of thrombin inhibitors with an azaphenylalanine scaffold: potency and selectivity enhancements via P2 optimization. Bioorganic & Medicinal Chemistry. 9(10). 2745–2756. 12 indexed citations
2.
Roux, Sébastiên, T. Tschopp, & HR Baumgartner. (1996). Effects of napsagatran (Ro 46-6240), a new synthetic thrombin inhibitor and of heparin in a canine model of coronary artery thrombosis: comparison with an ex vivo annular perfusion chamber model.. Journal of Pharmacology and Experimental Therapeutics. 277(1). 71–78. 15 indexed citations
3.
4.
Kirchhofer, Daniel, T. Tschopp, Beat Steiner, & HR Baumgartner. (1995). Role of collagen-adherent platelets in mediating fibrin formation in flowing whole blood. Blood. 86(10). 3815–3822. 48 indexed citations
5.
6.
Kirchhofer, Daniel, T. Tschopp, Paul Hadváry, & HR Baumgartner. (1994). Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors.. Journal of Clinical Investigation. 93(5). 2073–2083. 120 indexed citations
7.
Kirchhofer, Daniel, KS Sakariassen, Martine Clozel, et al.. (1993). Relationship between tissue factor expression and deposition of fibrin, platelets, and leukocytes on cultured endothelial cells under venous blood flow conditions. Blood. 81(8). 2050–2058. 64 indexed citations
9.
Kirchhofer, Daniel, KS Sakariassen, T. Tschopp, et al.. (1993). Relationship between tissue factor expression and deposition of fibrin, platelets, and leukocytes on cultured endothelial cells under venous blood flow conditions. Blood. 81(8). 2050–2058. 4 indexed citations
10.
Sakaríassen, Kjell S., Reto Müggli, Herbert Kühn, et al.. (1990). Collagen type III induced ex vivo thrombogenesis in humans. Role of platelets and leukocytes in deposition of fibrin.. Arteriosclerosis An Official Journal of the American Heart Association Inc. 10(2). 276–284. 91 indexed citations
12.
Müggli, Reto, et al.. (1985). 7-Bromo-1,5-dihydro-3,6-dimethylimidazo[2,1-b]quinazolin-2(3H)- one (Ro 15-2041), a potent antithrombotic agent that selectively inhibits platelet cyclic AMP-phosphodiesterase.. Journal of Pharmacology and Experimental Therapeutics. 235(1). 212–219. 19 indexed citations
13.
Müggli, Reto, et al.. (1983). Ro 15-2041 - A Selective Platelet Camp Phosphodiesterase Inhibitor with Antjthrombotic Properties. European Heart Journal. 4(suppl B). 18–18. 1 indexed citations
14.
Müggli, Reto, et al.. (1981). Isolation and characterization of a rabbit platelet secretory protein with anti heparin activity different from platelet factor 4. Cellular and Molecular Life Sciences. 37(6). 630. 1 indexed citations
15.
Müggli, Reto, et al.. (1981). Purification, Characterization And Radioimmunoassay Of A New Antiheparin Protein Secreted By Rabbit Platelets. Thrombosis and Haemostasis. 1 indexed citations
16.
Baumgartner, Hans R., T. Tschopp, Dominique Meyer, Vincent T. Turitto, & Harvey J. Weiss. (1981). Von Willebrand Factor In Platelet Interaction With Subendothelium. Thrombosis and Haemostasis. 2 indexed citations
17.
Baumgartner, Hans R., T. Tschopp, & Dominique Meyer. (1980). Shear Rate Dependent Inhibition of Platelet Adhesion and Aggregation on Collagenous Surfaces by Antibodies to Human Factor VIII/von Willebrand Factor. British Journal of Haematology. 44(1). 127–139. 124 indexed citations
18.
Tschopp, T., Hans R. Baumgartner, K Silberbauer, & H. Sinzinger. (1979). Platelet Adhesion and Platelet Thrombus Formation on Subendothelium of Human Arteries and Veins Exposed to Flowing Blood <i>in vitro</i>. A Comparison with Rabbit Aorta. Pathophysiology of Haemostasis and Thrombosis. 8(1). 19–29. 25 indexed citations
19.
Weiss, HJ, et al.. (1978). Correction by factor VIII of the impaired platelet adhesion to subendothelium in von Willebrand disease. Blood. 51(2). 267–279. 5 indexed citations
20.
Weiss, HJ, HR Baumgartner, T. Tschopp, VT Turitto, & Dalia Cohen. (1978). Correction by factor VIII of the impaired platelet adhesion to subendothelium in von Willebrand disease. Blood. 51(2). 267–279. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026